FFAR3 and gestational diabetes: Human studies corroborate these findings, showing that women with GDM exhibit decreased circulating levels of acetate, propionate, and butyrate, which correlate with altered expression of SCFA receptors (GPR41/43) and metabolic markers in placental tissue (Wang et al., 2022), affirming SCFAs as pivotal modulators of the gut-islet axis in pregnancy.